Hanmi Pharm, Stock Price -0.15% at This Time... Institutional Investors Net Sell 114,423 Shares in Last 5 Days

Hanmi Pharm is trading at 324,000 KRW as of 9:30 AM on the 11th, down 0.15% from the previous day. The trading volume is 63,448 shares, which is 9.63% of the previous day's volume. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.

On August 10, Gu Wan-seong, a researcher at NH Investment & Securities, announced a target price of 320,000 KRW for Hanmi Pharm, stating, "A licensing agreement for HM12525A technology was signed with MSD in the United States. Although the recovery of the pipeline value returned from Janssen is positive, it is already reflected in the stock price, so the additional upside is considered low. Also, the possibility of licensing the NASH treatment HM15211 (Triple Agonist) has decreased. The investment opinion is downgraded to Hold."

Over the past five days, individual investors have net purchased 70,882 shares of Hanmi Pharm, while foreigners and institutions have net purchased 66,155 shares and net sold 114,423 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.